321 related articles for article (PubMed ID: 21035017)
1. Adherence to antiretroviral therapy in pediatric patients with human immunodeficiency virus (HIV-1).
Burack G; Gaur S; Marone R; Petrova A
J Pediatr Nurs; 2010 Dec; 25(6):500-4. PubMed ID: 21035017
[TBL] [Abstract][Full Text] [Related]
2. Impact of different patterns of nonadherence on the outcome of highly active antiretroviral therapy in patients with long-term follow-up.
Knobel H; Urbina O; González A; Sorlí ML; Montero M; Carmona A; Guelar A
HIV Med; 2009 Jul; 10(6):364-9. PubMed ID: 19490179
[TBL] [Abstract][Full Text] [Related]
3. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
4. A time-to-prescription-refill measure of antiretroviral adherence predicted changes in viral load in HIV.
Grossberg R; Zhang Y; Gross R
J Clin Epidemiol; 2004 Oct; 57(10):1107-10. PubMed ID: 15528063
[TBL] [Abstract][Full Text] [Related]
5. Association between pharmacy medication refill-based adherence rates and cd4 count and viral-load responses: A retrospective analysis in treatment-experienced adults with HIV.
Townsend ML; Jackson GL; Smith R; Wilson KH
Clin Ther; 2007 Apr; 29(4):711-6. PubMed ID: 17617294
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal antiretroviral adherence among adolescents infected with human immunodeficiency virus.
Murphy DA; Belzer M; Durako SJ; Sarr M; Wilson CM; Muenz LR;
Arch Pediatr Adolesc Med; 2005 Aug; 159(8):764-70. PubMed ID: 16061785
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of a pill-swallowing training intervention to improve antiretroviral medication adherence in pediatric patients with HIV/AIDS.
Garvie PA; Lensing S; Rai SN
Pediatrics; 2007 Apr; 119(4):e893-9. PubMed ID: 17353298
[TBL] [Abstract][Full Text] [Related]
8. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
Panel de expertos de Gesida y Plan Nacional sobre el Sida
Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
[TBL] [Abstract][Full Text] [Related]
9. Use of a prescription-based measure of antiretroviral therapy adherence to predict viral rebound in HIV-infected individuals with viral suppression.
Cambiano V; Lampe FC; Rodger AJ; Smith CJ; Geretti AM; Lodwick RK; Holloway J; Johnson M; Phillips AN
HIV Med; 2010 Mar; 11(3):216-24. PubMed ID: 20002781
[TBL] [Abstract][Full Text] [Related]
10. Long-term utility of measuring adherence by self-report compared with pharmacy record in a routine clinic setting.
Fairley CK; Permana A; Read TR
HIV Med; 2005 Sep; 6(5):366-9. PubMed ID: 16156886
[TBL] [Abstract][Full Text] [Related]
11. Medication refill logistics and refill adherence in HIV.
Gross R; Zhang Y; Grossberg R
Pharmacoepidemiol Drug Saf; 2005 Nov; 14(11):789-93. PubMed ID: 15880515
[TBL] [Abstract][Full Text] [Related]
12. Differential impact of adherence on long-term treatment response among naive HIV-infected individuals.
Lima VD; Harrigan R; Murray M; Moore DM; Wood E; Hogg RS; Montaner JS
AIDS; 2008 Nov; 22(17):2371-80. PubMed ID: 18981777
[TBL] [Abstract][Full Text] [Related]
13. Adherence to directly observed antiretroviral therapy among human immunodeficiency virus-infected prison inmates.
Wohl DA; Stephenson BL; Golin CE; Kiziah CN; Rosen D; Ngo B; Liu H; Kaplan AH
Clin Infect Dis; 2003 Jun; 36(12):1572-6. PubMed ID: 12802758
[TBL] [Abstract][Full Text] [Related]
14. Factors associated with non-adherence to long-term highly active antiretroviral therapy: a 10 year follow-up analysis with correction for the bias induced by missing data.
Protopopescu C; Raffi F; Roux P; Reynes J; Dellamonica P; Spire B; Leport C; Carrieri MP;
J Antimicrob Chemother; 2009 Sep; 64(3):599-606. PubMed ID: 19602563
[TBL] [Abstract][Full Text] [Related]
15. Predictors of adherence to antiretroviral medications in children and adolescents with HIV infection.
Williams PL; Storm D; Montepiedra G; Nichols S; Kammerer B; Sirois PA; Farley J; Malee K;
Pediatrics; 2006 Dec; 118(6):e1745-57. PubMed ID: 17101712
[TBL] [Abstract][Full Text] [Related]
16. Low rate of virological failure and maintenance of susceptibility to HIV-1 protease inhibitors with first-line lopinavir/ritonavir-based antiretroviral treatment in clinical practice.
Prosperi MC; Zazzi M; Punzi G; Monno L; Colao G; Corsi P; Di Giambenedetto S; Meini G; Ghisetti V; Bonora S; Pecorari M; Gismondo MR; Bagnarelli P; Carli T; De Luca A;
J Med Virol; 2010 Dec; 82(12):1996-2003. PubMed ID: 20981785
[TBL] [Abstract][Full Text] [Related]
17. Adherence to highly active antiretroviral therapy predicts virologic outcome at an inner-city human immunodeficiency virus clinic.
McNabb J; Ross JW; Abriola K; Turley C; Nightingale CH; Nicolau DP
Clin Infect Dis; 2001 Sep; 33(5):700-5. PubMed ID: 11486292
[TBL] [Abstract][Full Text] [Related]
18. Predictors of short-term success of antiretroviral therapy in HIV infection.
Oette M; Kroidl A; Göbels K; Stabbert A; Menge M; Sagir A; Kuschak D; O'hanley T; Bode JG; Häussinger D
J Antimicrob Chemother; 2006 Jul; 58(1):147-53. PubMed ID: 16687458
[TBL] [Abstract][Full Text] [Related]
19. Adherence to antiretroviral therapy by human immunodeficiency virus-infected patients.
Turner BJ
J Infect Dis; 2002 May; 185 Suppl 2():S143-51. PubMed ID: 12001036
[TBL] [Abstract][Full Text] [Related]
20. Risk of high-level viraemia in HIV-infected patients on successful antiretroviral treatment for more than 6 months.
Engsig FN; Omland LH; Larsen MV; Rasmussen LD; Qvist T; Gerstoft J; Obel N
HIV Med; 2010 Aug; 11(7):457-61. PubMed ID: 20158527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]